95 Participants NeededMy employer runs this trial

Pulsed Radiofrequency for Neuropathic Pain

Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a treatment called non-invasive pulsed radiofrequency (NIPRF) to determine its effectiveness in reducing chronic neuropathic pain from nerve injuries after surgery or trauma. Participants will receive either the active NIPRF treatment, which uses a device to send gentle pulses to the affected nerves, or a non-active treatment that mimics the process without delivering actual pulses. Individuals with persistent nerve pain after an injury, despite trying other treatments, might be suitable for this trial.

As a combined Phase 2 and Phase 3 trial, this research measures the treatment's effectiveness in an initial, smaller group and represents the final step before FDA approval. Participants have the opportunity to contribute to advancing pain management solutions.

Do I have to stop taking my current medications for the trial?

The trial requires that you keep your current pain medication dosage stable for at least 30 days before starting and not try any new pain medications for three weeks after joining the study.

What prior data suggests that this non-invasive pulsed radiofrequency is safe for treating chronic neuropathic pain?

Previous studies have shown that pulsed radiofrequency (PRF) is very safe for treating chronic pain. Research indicates a low rate of complications, making it a trusted option for many people. One study found that high-voltage PRF did not cause more side effects than the regular version, supporting its safety. PRF uses electrical fields to manage pain without destroying tissue. This method has proven effective for nerve pain, which results from nerve damage. Overall, PRF is considered a safe and effective choice for managing chronic pain.12345

Why are researchers excited about this trial's treatment?

Most treatments for neuropathic pain involve medications like gabapentin or pregabalin, which work by altering nerve signals. However, pulsed radiofrequency therapy offers a different approach by using a high-frequency magnetic field to target and treat nerves non-invasively. Researchers are excited about this treatment because it promises a non-drug alternative that might reduce pain with fewer side effects. Additionally, the use of a non-invasive device means there’s no need for surgical intervention, making it a much simpler and potentially safer option for patients. This innovation could be particularly beneficial for those who haven't found relief with traditional medications.

What evidence suggests that non-invasive pulsed radiofrequency is effective for chronic neuropathic pain?

Studies have shown that pulsed radiofrequency (PRF) can greatly reduce nerve-related pain. Research indicates that PRF treatments lowered pain levels at two weeks, one month, and three months post-treatment. One study found that over 60% of patients experienced significant pain improvement without surgery. Another study demonstrated that PRF was more effective than standard treatments for certain types of nerve pain. In this trial, participants will receive either the active non-invasive pulsed radiofrequency treatment or a non-active sham treatment. Overall, these findings suggest that non-invasive pulsed radiofrequency could be a promising option for managing long-term nerve pain, especially after nerve injuries.13678

Are You a Good Fit for This Trial?

This trial is for adults (18+) with chronic neuropathic pain after a peripheral nerve injury, who have had at least 50% pain relief from a nerve block and still have significant pain (5/10 or higher) despite trying other treatments for at least 12 weeks. Participants must be able to complete assessments and keep their medication stable.

Inclusion Criteria

I had at least 50% pain relief after a nerve block test.
I have had ongoing pain for at least 12 weeks despite standard treatments.
My pain level at the affected site is 5 or higher out of 10.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive non-invasive pulsed radiofrequency treatment once weekly for three weeks

3 weeks
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Invasive Pulsed Radiofrequency

Trial Overview

The study compares non-invasive pulsed radiofrequency therapy using an FDA-approved device (Stimpod) to a non-active treatment in people with chronic neuropathic pain. The goal is to see if this therapy can reduce pain more effectively than no active treatment.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Active TreatmentActive Control1 Intervention
Group II: Non-Active TreatmentPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

Citations

Treatment of Peripheral Nerves With Pulsed Radiofrequency

Results: Pain scores were statistically lower at two weeks, one month, and three months after therapy. Overall, eight (47%) and five (29%) ...

Full article: Efficacy and Safety of High-Voltage Pulsed ...

Our study supported that high-voltage PRF attained more satisfactory efficacy than standard-voltage PRF without increased side effects.

Efficacy of pulsed radiofrequency stimulation in patients ... - PMC

The results showed that compared to steroid injections alone, the combination of PRF and cervical nerve block significantly reduced the pain scores of patients ...

Efficacy of Pulsed Radiofrequency Stimulation in Patients ...

Methods: A PubMed search was conducted for papers published from January 1, 1980 to August. 31, 2017 that used PRF to treat peripheral neuropathic pain.

Effectiveness of pulsed radiofrequency treatment on...

We analyzed all the data in each included study, and the overall outcome showed that cervical radicular pain was significantly reduced after PRF on DRG. In ...

Pulsed Radiofrequency Treatment: Evidence for and ...

Conclusion: PRF is a safe, non-ablative technique that modulates pain through electrical fields. It has demonstrated effectiveness in neuropathic pain, ...

The longer term effect of pulsed radiofrequency for ...

This study reports the effect of pulsed RF in four patients with neuropathic pain who had previously failed to respond to conventional therapy.

Pulsed Radiofrequency Treatment in Chronic Pain ...

Efficacy and safety of pulsed radiofrequency as a method of dorsal root ganglia stimulation for treatment of non-neuropathic pain: a systematic review. BMC ...